Respiratory Clinical Trials

Statistical methods in respiratory trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All respiratory trials

865 results

• Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 47NCT03734822
• Comparative Effectiveness of COPD Treatments: Complete Statistical AnalysisIndependent statistical analysis of Comparative Effectiveness of COPD Treatments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03376295).Phase NAResults postedn = 3,954NCT03376295
• Comparative Effectiveness Study of Bubble CPAP Devices in the NICU: Complete Statistical AnalysisIndependent statistical analysis of Comparative Effectiveness Study of Bubble CPAP Devices in the NICU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02392806).Phase NAResults postedn = 43NCT02392806
• Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS: Complete Statistical AnalysisIndependent statistical analysis of Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 360NCT00519636
• Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism: Complete Statistical AnalysisIndependent statistical analysis of Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 18NCT01458639
• Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery: Complete Statistical AnalysisIndependent statistical analysis of Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in…Phase 3Results postedn = 19NCT04588246
• Comparison Between Gastric and Post Pyloric Tube Feedings in Children With Bronchiolitis Requiring High Flow Nasal Cannula: Complete Statistical AnalysisIndependent statistical analysis of Comparison Between Gastric and Post Pyloric Tube Feedings in Children With Bronchiolitis Requiring High Flow Nasal Cannula: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 40NCT03346850
• Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 4Results postedn = 17NCT00685035
• Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 118NCT02566902
• Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 136NCT00626028
• Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 399NCT00065182
• Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 13NCT04533646
• Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 150NCT00845195
• Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 140NCT00057837
• Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer: primary endpoint results, effect estimate…Phase 2Results postedn = 307NCT01657799
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED): primary endpoint results,…Phase 3Results postedn = 843NCT00337428
• Connected Healthcare for Individuals Living at Home With Chronic Conditions: Complete Statistical AnalysisIndependent statistical analysis of Connected Healthcare for Individuals Living at Home With Chronic Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04339296).Phase NAResults postedn = 91NCT04339296
• CONTAINIndependent statistical analysis of Inhaled Ciclesonide for Outpatients With COVID19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04435795).Phase 2/3Results postedn = 215NCT04435795
• COPDIndependent statistical analysis of A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 158NCT00457951
• COPDIndependent statistical analysis of COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 34NCT02251496
• COPDGeneIndependent statistical analysis and educational interpretation of the COPDGene study, evaluating genetic factors associated with chronic obstructive pulmonary disease, emphysema, bronchitis, and related baseline measurements.n = 10,718NCT00608764
• COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662060).Phase 2Results postedn = 120NCT04662060
• COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662073).Phase 2Results postedn = 2NCT04662073
• CORONAIndependent statistical analysis of the randomized phase 3 CORONA trial of levilimab versus placebo in patients with severe COVID-19, including the primary endpoint, trial design, planned statistical analysis, and interpretation.Phase 3n = 206NCT04397562
• COV-BARRIERComplete statistical analysis of the COV-BARRIER phase 3 trial of baricitinib plus standard of care versus placebo plus standard of care in participants with COVID-19, including trial design, endpoints, statistical methodology, reported…Phase 3Results postedn = 1,525NCT04421027
• COV002Independent statistical analysis of COV002 (NCT04400838), a randomized phase 2/3 trial investigating ChAdOx1 nCoV-19 for prevention of COVID-19 in adults, including its design, endpoints, planned statistical methods, and interpretation.Phase 2/3n = 10,811NCT04400838
• COV003Independent statistical analysis and educational interpretation of COV003, a phase 3 randomized study of ChAdOx1 nCoV-19 for prevention of COVID-19 disease confirmed with PCR.Phase 3n = 10,300NCT04536051
• COVID SAFE 2Independent statistical analysis of COVID-19 Screening Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05216627).Phase NAResults postedn = 61NCT05216627
• COVID-19Independent statistical analysis of Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05973006).Phase 3Results postedn = 400NCT05973006
• COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05584189).Phase NAResults postedn = 99NCT05584189
• COVID-19 PEPComplete statistical analysis of the randomized phase 3 COVID-19 PEP trial of hydroxychloroquine versus placebo for post-exposure prophylaxis and preemptive therapy for SARS-CoV-2.Phase 3Results postedn = 1,312NCT04308668
• COVID-19 PrEP HCW HCQ Study: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 PrEP HCW HCQ Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04354870).Phase 2Results postedn = 130NCT04354870
• COVID-19 Project ECHO in Nursing Homes: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Project ECHO in Nursing Homes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04499391).Phase NAResults postedn = 136NCT04499391
• COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06547814).Phase NAResults postedn = 20NCT06547814
• COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): Complete Statistical AnalysisIndependent statistical analysis of COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04595773).Phase NAResults postedn = 48NCT04595773
• COViNOXIndependent statistical analysis of A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 191NCT04421508
• COVIPACT 2Independent statistical analysis of Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 29NCT04747249
• CoVPN 3006A detailed statistical analysis of CoVPN 3006, a randomized phase 3 crossover study evaluating Moderna COVID-19 Vaccine against SARS-CoV-2 infection and COVID-19 disease through the Month 4 study visit.Phase 3Results postedn = 1,923NCT04811664
• CPAP to Treat Cognitive Dysfunction in MS: Complete Statistical AnalysisIndependent statistical analysis of CPAP to Treat Cognitive Dysfunction in MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02544373).Phase NAResults postedn = 135NCT02544373
• Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD: Complete Statistical AnalysisIndependent statistical analysis of Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD: primary endpoint results, effect estimate with…Phase 3Results postedn = 80NCT02454959
• CROWN CORONAIndependent statistical analysis of the randomized phase 3 CROWN CORONA trial evaluating M-M-R II vaccine versus placebo for prevention of symptomatic COVID-19, including Bayesian logistic regression, risk differences, confidence intervals, p-values, and…Phase 3Results postedn = 3,411NCT04333732
• CROWN CORONAIndependent statistical analysis of CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04333732).Phase 3Results postedn = 3,411NCT04333732
• Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 8NCT00514215
• Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis: Complete Statistical AnalysisIndependent statistical analysis of Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 1Results postedn = 9NCT00890617
• CTREPHIndependent statistical analysis of Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH): primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 105NCT01416636
• Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV: Complete Statistical AnalysisIndependent statistical analysis of Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2/3Results postedn = 1,354NCT00080119
• Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 87NCT00966277
• Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 35NCT00459342
• DB2113361Independent statistical analysis of the randomized phase 3 DB2113361 trial evaluating UMEC/VI 125/25 µg and its components in chronic obstructive pulmonary disease, with emphasis on repeated-measures analysis of trough FEV1.Phase 3Results postedn = 1,493NCT01313637
• DB2113373Complete statistical analysis of the phase 3 DB2113373 trial of UMEC/VI 62.5/25 µg, its components, and placebo in chronic obstructive pulmonary disease, including trial design, FEV1 methodology, mixed-effects modeling, reported estimates, confidence…Phase 3Results postedn = 1,538NCT01313650

← All therapeutic areas